Papers

Research literature with structured metadata.

Trials

Registered studies by status, phase, and compound.

Topics

Indications and themes psychedelics are researched for.

Compounds

Evidence across molecules with rich data.

Countries

Regulation, access, and research activity by region.

Stakeholders

Organizations shaping the space across research, policy, and funding.

People

Investigators, clinicians, and authors with mapped output.

Courses

Training programs and certifications across modalities.

Events

Conferences, workshops, and convenings by date and focus.

Results

Compare outcome data across trials and publications.

Research recaps

Monthly evidence summaries with key takeaways.

Map of research

Landscape view of trials, compounds, and outcomes.

Newsletter

Weekly or daily updates on trials, publications, analysis, and more.

Research Groups

Worldwide map of psychedelic research centres by region.

Road to Access

Science, regulation, and economics on the path to patient access.

Research Network

Interactive co-authorship map of psychedelic researchers.

Top papers

Find needles in the haystack of psychedelic research per topic.

Pricing
StakeholdersAdjunct IndustriesTechnology, Data, & Software PlatformsData Analytics
2 Organisations

Data Analytics

Data analytics platforms processing clinical, genomic, and real-world data to advance psychedelic medicine insights.

All Organisations

Nectara

Psychedelic-focused digital platform supporting protocolized care operations, patient journey tracking, and program management for providers and organizations.

View Profile

Osmind

Psychiatry technology and real-world evidence platform supporting interventional mental health care, including psychedelic-assisted therapy workflows and psilocybin outcomes initiatives.

View Profile

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.